A team of researchers from the Technical University of Kenya (TU-K) is spearheading a groundbreaking initiative to combat antimicrobial resistance (AMR) through phage therapy—a revolutionary alternative to antibiotics. This research, focused on phage isolation, genome analysis, and comparative genomics.
While phage therapy has been successfully explored in the Global North, Kenyan researchers are now advancing its potential as a homegrown solution to drug-resistant bacterial infections. Speaking at the conclusion of a 10-day workshop and research sequencing exercise jointly held at TU-K and the Kenya Institute of Primate Research (KIPRE), Dr. James Munyao emphasized the urgency of finding alternative treatments for bacterial infections that no longer respond to antibiotics.